FDA-Proposed Warning For OTC Bronchodilators “Alarming” – Wyeth
This article was originally published in The Tan Sheet
Executive Summary
FDA should re-word a cardiovascular warning statement it has proposed for OTC bronchodilator products because the statement is "unnecessarily alarming" and "goes beyond that which is supported by data," Wyeth Consumer Healthcare maintains